(Q39437927)

12 September 2017

title

GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution (English)

1 reference

12 September 2017

1 reference

1 reference

4

1 reference

12 September 2017

F Vilardell

5

0 references

Elena Mercade

object named as

E Mercade

7

0 references

author name string

S Guedan

1

1 reference

12 September 2017

D Grases

2

1 reference

12 September 2017

J J Rojas

3

1 reference

12 September 2017

R Vile

6

1 reference

12 September 2017

M Cascallo

8

1 reference

12 September 2017

R Alemany

9

1 reference

12 September 2017

language of work or name

1 reference

24 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

19

1 reference

12 September 2017

issue

11

1 reference

12 September 2017

page(s)

1048-1057

1 reference

Replicative adenoviruses for cancer therapy

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Oncolytic viral therapies - the clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Intelligent design: combination therapy with oncolytic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Use of replicating oncolytic adenoviruses in combination therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Armed replicating adenoviruses for cancer virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Psoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

Adenovirus Release from the Infected Cell as a Key Factor for Adenovirus Oncolysis~!2009-10-09~!2010-02-25~!2010-05-26~!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.184

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2011.184

1 reference

12 September 2017

1 reference